Scar tissue in the uterus doesn't have to end your pregnancy hopes. Advanced hysteroscopic treatment and comprehensive fertility care at StemRx IVF.
Asherman's syndrome is a condition where bands of scar tissue (intrauterine adhesions) form inside the uterus, causing the uterine walls to stick together. This can disrupt menstrual function, cause pain, and significantly impact fertility by reducing the surface area available for embryo implantation.
Also known as intrauterine adhesions (IUAs) or uterine synechiae.
Acquired condition (not congenital)
Often follows uterine procedures
Treatable with proper care
Symptoms can vary depending on the extent of adhesions. Some women may have no symptoms, while others experience significant changes.
Asherman's syndrome is almost always acquired rather than congenital. It results from injury to the basalis layer of the endometrium, most commonly during uterine procedures.
Treatment is tailored to the severity of adhesions and your fertility goals.
Success rates vary based on individual factors including age, adhesion severity, surgical expertise, and post-operative care. These are general estimates from published studies.
Hysteroscopic adhesiolysis is a minimally invasive surgical procedure where adhesions are carefully divided and removed under direct vision using a hysteroscope (thin camera inserted through the cervix).
Most women resume normal activities within 2–3 days. Mild cramping and spotting are normal for a few days post-procedure.
After hysteroscopic adhesiolysis, comprehensive post-operative care is essential to prevent adhesions from reforming and promote endometrial healing.
Comprehensive post-operative care significantly improves pregnancy outcomes. Following your doctor's instructions carefully is crucial for success.
With proper treatment and post-operative care, many women with Asherman's syndrome successfully conceive and carry pregnancies to term.
Women under 35 are more likely to conceive after treatment. Age, adhesion severity, and ovarian reserve all influence outcomes. Your fertility specialist will provide personalised guidance based on your situation.
While many women successfully conceive after treatment, pregnancies following Asherman's syndrome require careful monitoring due to increased risks.
Despite these risks, many women with treated Asherman's syndrome have successful, healthy pregnancies. Early and consistent prenatal care with a high-risk obstetrician is recommended.
For severe or recurrent cases, advanced therapies may be considered.
Emerging Therapy
Recent case reports have documented successful pregnancies in women with severe Asherman's syndrome following treatment with umbilical cord-derived mesenchymal stem cells. This therapy aims to regenerate the damaged endometrium.
This is an investigational therapy and is not yet standard treatment. Discuss with your fertility specialist to understand availability, evidence, and suitability for your case.
For women who don't conceive naturally after adhesiolysis, IVF can be highly effective. Ensuring the uterine cavity is optimally prepared before embryo transfer is critical for success.
Turning Hope Into Reality
Don't wait if you suspect Asherman's syndrome. Early diagnosis and expert treatment significantly improve outcomes. Schedule a consultation with our fertility specialists.
Turning Hope Into Reality